Scarica l'app Stockscreener
21.77
2.16%
-0.48
Dopo l'orario di chiusura:
21.77
Precedente Chiudi:
$22.25
Aprire:
$22.25
Volume 24 ore:
1,497
Relative Volume:
0.32
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-12.57%
1M Prestazione:
-23.13%
6M Prestazione:
+122.82%
1 anno Prestazione:
+46.60%
Intervallo 1D:
$21.77
$22.25
Intervallo di 1 settimana:
$21.77
$27.61
Portata 52W:
$5.45
$29.99
Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile
Nome
Newamsterdam Pharma Company N V
Settore
Industria
Telefono
31 35 206 2971
Indirizzo
Gooimeer 2-35, Naarden
Confronta NAMSW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAMSW
Newamsterdam Pharma Company N V
|
21.77 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie
NewAmsterdam Pharma (NASDAQ:NAMS) Given New $50.00 Price Target at Stifel Nicolaus - Defense World
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Understanding Momentum Shifts in (NAMSW) - news.stocktradersdaily.com
Is It Too Late To Consider NewAmsterdam Pharma After Its Strong 2025 Share Price Rally? - Yahoo Finance
Frazier Life Sciences Management L.P. Has $300.75 Million Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V. $NAMS Holdings Lifted by Maverick Capital Ltd. - MarketBeat
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (NAMS) for Rule-Based Strategy - news.stocktradersdaily.com
It is Poised to be a Bull Market for NewAmsterdam Pharma Company NV (NAMS) - setenews.com
Stempoint Capital LP Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World
NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Affinity Asset Advisors LLC - Defense World
NewAmsterdam Pharma Company Grants Inducement Share Options to New Hires - Quiver Quantitative
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Saturn V Capital Management LP Buys 104,342 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock gain from lower inflationMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correction2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock see PE expansionJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap DownHere's Why - MarketBeat
NAMS: PREVAIL CVOT remains on track for 2026, with regulatory and commercial momentum building - TradingView
JPMorgan Chase & Co. Increases Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
How NewAmsterdam Pharma Company N.V. (KH6) stock trades after earningsWeekly Trade Analysis & Consistent Profit Trade Alerts - Newser
Transcript : NewAmsterdam Pharma Company N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 03 - marketscreener.com
A better buy-in window may exist right now for NewAmsterdam Pharma Company NV (NAMS) - Setenews
Is NewAmsterdam Pharma Company N.V. (KH6) stock a defensive play amid uncertaintyEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Will NewAmsterdam Pharma Company N.V. stock benefit from commodity pricesGap Down & Smart Money Movement Alerts - Newser
Will NewAmsterdam Pharma Company N.V. (KH6) stock announce special dividendWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a dividend growth opportunity2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Why NewAmsterdam Pharma Company N.V. (KH6) stock signals breakout potential2025 Stock Rankings & Low Drawdown Momentum Ideas - Newser
Franklin Resources Inc. Purchases 78,300 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
(NAMS) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock outperform in 2025 bull marketPortfolio Gains Report & Technical Buy Zone Confirmation - BỘ NỘI VỤ
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December - Sahm
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month HighHere's Why - MarketBeat
NewAmsterdam Pharma stock hits all-time high at 41.56 USD - Investing.com India
NewAmsterdam Pharma stock hits all-time high at 41.56 USD By Investing.com - Investing.com Australia
Discipline and Rules-Based Execution in NAMSW Response - news.stocktradersdaily.com
What drives NewAmsterdam Pharma Company NV KH6 stock priceDebt-to-Equity Ratio Analysis & Get Ahead with Our Profit-Packed Picks - earlytimes.in
Bank of New York Mellon Corp Acquires New Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Can a trend reversal in NewAmsterdam Pharma Company N.V. Equity Warrant lead to recovery - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Movers & Risk Controlled Stock Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsQuarterly Risk Review & Weekly Market Pulse Alerts - newser.com
Will NewAmsterdam Pharma Company N.V. stock maintain dividend yield - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock a fit for income portfoliosOil Prices & Long-Term Growth Stock Strategies - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in high volatility marketsPortfolio Gains Report & Safe Entry Zone Identification - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com
How NewAmsterdam Pharma Company N.V. (KH6) stock compares with tech leaders2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceIndex Update & Weekly High Momentum Picks - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflation2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock recover faster than marketJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Newamsterdam Pharma Company N V Azioni (NAMSW) Dati Finanziari
Non sono disponibili dati finanziari per Newamsterdam Pharma Company N V (NAMSW). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Capitalizzazione:
|
Volume (24 ore):